We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,584 hedge funds and large institutions have $251B invested in Johnson & Johnson in 2018 Q3 according to their latest regulatory filings, with 84 funds opening new positions, 1,107 increasing their positions, 1,110 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more first-time investments, than exits

New positions opened: 84 | Existing positions closed: 69

18% more funds holding in top 10

Funds holding in top 10: 553651 (+98)

14% more capital invested

Capital invested by funds: $219B → $251B (+$31.6B)

0.08% more ownership

Funds ownership: 67.58%67.66% (+0.08%)

0% less repeat investments, than reductions

Existing positions increased: 1,107 | Existing positions reduced: 1,110

0% less funds holding

Funds holding: 2,5932,584 (-9)

26% less call options, than puts

Call options by funds: $1.49B | Put options by funds: $2.02B

Holders
2,584
Holders Change
-9
Holders Change %
-0.35%
% of All Funds
59.06%
Holding in Top 10
651
Holding in Top 10 Change
+98
Holding in Top 10 Change %
+17.72%
% of All Funds
14.88%
New
84
Increased
1,107
Reduced
1,110
Closed
69
Calls
$1.49B
Puts
$2.02B
Net Calls
-$525M
Net Calls Change
-$83.1M
Name Holding Trade Value Shares
Change
Change in
Stake
VCAM
801
Van Cleef Asset Management
Ohio
$11.1M -$180K -1,353 -2%
CSS
802
Cubist Systematic Strategies
Connecticut
$11.1M +$2.35M +17,693 +28%
CIP
803
Chartwell Investment Partners
Pennsylvania
$11.1M +$1.7M +12,775 +19%
LI
804
Lafayette Investments
Maryland
$11M -$1.04M -7,800 -9%
AHC
805
Adell Harriman & Carpenter
Texas
$11M -$32.7K -246 -0.3%
NONA
806
Ninety One North America
New York
$11M -$1.14M -8,596 -10%
AAF
807
Andra AP-fonden
Sweden
$10.9M +$1.09M +8,200 +12%
BCAM
808
Boston Common Asset Management
Massachusetts
$10.9M -$1.76M -13,266 -14%
CB
809
Community Bank
New York
$10.8M -$269K -2,025 -3%
M
810
MOTCO
Texas
$10.8M +$31.6K +238 +0.3%
LKIM
811
Lawson Kroeker Investment Management
Nebraska
$10.8M -$63.8K -480 -0.6%
BAS
812
Brown Advisory Securities
Maryland
$10.8M -$85K -640 -0.8%
YIA
813
YHB Investment Advisors
Connecticut
$10.8M -$50.5K -380 -0.5%
BA
814
Bridgewater Associates
Connecticut
$10.8M -$4.27M -32,135 -29%
VCA
815
Verdence Capital Advisors
Maryland
$10.7M +$458K +3,445 +5%
FA
816
FDx Advisors
Illinois
$10.7M +$716K +5,391 +7%
CAMG
817
CWA Asset Management Group
Florida
$10.7M +$110K +828 +1%
ARMC
818
American Research & Management Company
Massachusetts
$10.7M -$89.7K -675 -0.9%
WIC
819
Wilkins Investment Counsel
Massachusetts
$10.7M -$73.1K -550 -0.7%
FNBT
820
FineMark National Bank & Trust
Florida
$10.6M -$1.85M -13,918 -15%
MAM
821
Meeder Asset Management
Ohio
$10.5M +$2.57M +19,318 +34%
ICP
822
Ironvine Capital Partners
Nebraska
$10.5M +$86K +647 +0.9%
DWM
823
Dorchester Wealth Management
Quebec, Canada
$10.5M +$606K +4,561 +6%
BA
824
Boston Advisors
Massachusetts
$10.5M +$163K +1,227 +2%
BHTS
825
Bar Harbor Trust Services
Maine
$10.5M -$150K -1,129 -1%

JNJ Hedge Fund Activity: Q3 2018 in Review

2,584 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q3 2018, worth a combined $251B — up 14% from $219B a quarter earlier.

Buyers outnumbered sellers: 84 funds opened new JNJ positions and 69 closed out — a net gain of 15 holders — while 1,107 added to existing stakes and 1,110 trimmed.

The largest buyer was Capital International Investors, adding an estimated $2.49B. The largest seller was Capital World Investors, cutting an estimated $2.21B.

  • 2,584 institutional investors held Johnson & Johnson (JNJ) as of Q3 2018, down from 2,593 in Q2 2018.
  • Funds reported $251B of Johnson & Johnson stock for Q3 2018, up 14% quarter-over-quarter.
  • 84 funds opened new Johnson & Johnson positions in Q3 2018 and 69 closed out, a net change of +15 holders.
  • The largest Johnson & Johnson buyer in Q3 2018 was Capital International Investors, an estimated $2.49B added.
  • The largest Johnson & Johnson seller in Q3 2018 was Capital World Investors, an estimated $2.21B sold.

Based on aggregated 13F filings for Q3 2018.